Assignee
SEQIRUS INC
US·0 granted patents·11 pending applications·0 citations·filing 2021–2023
Top patents by PatentIndex Score
11 records- 0157US2024047083A1Libraries of data that enable production of pandemic-ready vaccines and methods of preparing the sameSEQIRUS INC·Filed 2022·Application pending·0 cites
- 0254US2024425454A1Ionizable cationic compoundSEQIRUS INC·Filed 2022·Application pending·0 cites
- 0354US2026071191A1Modified influenza virusesSEQIRUS INC·Filed 2023·Application pending·0 cites
- 0454US2024415772A1Ionizable cationic lipid for messenger rna deliverySEQIRUS INC·Filed 2022·Application pending·0 cites
- 0554US2026034204A1Rna encoding virus-like particles and uses thereofSEQIRUS INC·Filed 2023·Application pending·0 cites
- 0653US2025281596A1Ionizable cationic compoundSEQIRUS INC·Filed 2022·Application pending·0 cites
- 0753US2025114311A1Ionizable cationic compounds for messenger rna deliverySEQIRUS INC·Filed 2022·Application pending·0 cites
- 0846US2024024460A1Self-replicating rna and uses thereofSEQIRUS INC·Filed 2021·Application pending·0 cites
- 0944US2026048023A1Lipid nanoparticle comprising a dna-binding proteinSEQIRUS INC·Filed 2023·Application pending·0 cites
- 1043US2024024455A1Multicistronic rna vaccines and uses thereofSEQIRUS INC·Filed 2021·Application pending·0 cites
- 1140US2024398941A1Lipid nanoparticle comprising a nucleic acid-binding proteinSEQIRUS INC·Filed 2022·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →